We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SD:NYSESandRidge Energy, Inc. Analysis

Data as of 2026-05-26 - not real-time

$15.26

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

SandRidge Energy posted a solid Q1 2026, with revenue climbing ~17% YoY and profit margins above 45%, while the board lifted the quarterly dividend by 8% to $0.13 and added a one‑time $0.20 payout, underscoring cash strength. Operating cash flow rose to $34.4 M and the balance sheet remains tight with debt under $2 M, delivering a low debt‑to‑equity of 0.32. Technically, the stock sits just above its 20‑day SMA (≈15.26) and is bounded by support at $14.37 and resistance near $16.09; RSI at 49 and a bullish MACD histogram suggest a neutral‑to‑slightly‑upward bias. Valuation metrics are compelling: a trailing PE of ~7.4 versus an industry average of ~21.6, a price‑to‑book near parity, and a DCF‑derived fair value far above the current $15.26 price, indicating potential undervaluation. The 3.4% dividend yield, coupled with a modest 23% payout ratio, appears sustainable given the strong cash generation. However, 30‑day volatility is high (~41%) and daily volume is well below its 10‑day average, flagging liquidity concerns. Overall, the company blends attractive income, solid fundamentals, and a discounted valuation, but investors should remain mindful of sector cyclicality and price volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Dividend increase and special payout boost income appeal
  • Technical indicators are neutral with support intact
  • High short‑term volatility and low trading volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation gap (PE ~7.4 vs industry ~21.6)
  • Sustained earnings growth and strong cash flow
  • Attractive dividend yield with low payout ratio

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Energy sector cyclicality introduces macro risk
  • Long‑term undervaluation relative to DCF fair value
  • Robust balance sheet supports dividend continuity

Key Metrics & Analysis

Financial Health

Revenue Growth16.80%
Profit Margin46.37%
P/E Ratio7.4
ROE15.30%
ROA6.40%
Debt/Equity0.32
P/B Ratio1.1
Op. Cash Flow$99.6M
Free Cash Flow$-6447875
Industry P/E21.6

Technical Analysis

TrendNeutral
RSI49.1
Support$14.37
Resistance$16.09
MA 20$15.26
MA 50$15.57
MA 200$14.17
MACDBullish
VolumeStable
Fear & Greed Index91.36

Valuation

Fair Value$51.89
Target Price$15.00
Upside/Downside-1.70%
GradeUndervalued
TypeBlend
Dividend Yield3.40%

Risk Assessment

Beta-0.25
Volatility40.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.